Findings expand upon earlier data, providing new noninvasive options
Cleveland Clinic is the first to investigate photonic nanoparticles as a potential kidney stone treatment
Management of high-risk RMSK in the pre-and current eras of neoadjuvant therapy
Clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Reflex testing led to substantially fewer provider recommendations for prostate biopsy and MRI
The multidisciplinary research team reported their findings in JAMA
Physicians explain findings from a recent study
Study reviews institutional experience
Information on the microbiome and urologic pathologies remain relatively limited
New grant will fund work to map human bladder and ureter at a cellular and molecular level